| Dr Harvey Aj Hopkins, MD | |
|
1500 S. 48th Street, Suite 800, Lincoln, NE 68506-1200 | |
| (402) 483-8600 | |
| (402) 483-8689 |
| Full Name | Dr Harvey Aj Hopkins |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 37 Years |
| Location | 1500 S. 48th Street, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871597583 | NPI | - | NPPES |
| 290008149 | Other | NE | RAILROAD MEDICARE |
| 290008149 | Other | IA | RAILROAD MEDICARE |
| 1904706 | Medicaid | IA | |
| 10026942607 | Medicaid | NE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryan Medical Center | Lincoln, NE | Hospital |
| Community Medical Center, Inc. | Falls city, NE | Hospital |
| Chi Health St. Elizabeth | Lincoln, NE | Hospital |
| Chi Health Lakeside | Omaha, NE | Hospital |
| Great Plains Health | North platte, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bryan Hospital Kearney | 5991195547 | 91 |
| Columbus Community Hospital Inc | 7517954944 | 73 |
| Community Memorial Hospital District | 7517856859 | 24 |
| Grand Island Regional Medical Center | 0143659508 | 11 |
| Nebraska Pulmonary Specialties Llc | 3072412881 | 30 |
| North Platte Nebraska Hospital Corporation | 6507856697 | 181 |
| Think Aksarben Llc | 9638394505 | 87 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | The Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437184652 PECOS PAC ID: 3476453267 Enrollment ID: O20040128001100 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Community Memorial Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336155134 PECOS PAC ID: 7517856859 Enrollment ID: O20040313000441 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Regional West Physicians Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306910534 PECOS PAC ID: 2062301609 Enrollment ID: O20040315001274 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Columbus Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427152131 PECOS PAC ID: 7517954944 Enrollment ID: O20040428000541 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | North Platte Nebraska Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700855533 PECOS PAC ID: 6507856697 Enrollment ID: O20040512000889 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Providence Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801867494 PECOS PAC ID: 4587629928 Enrollment ID: O20041124000342 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Harlan County Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124035225 PECOS PAC ID: 8325088214 Enrollment ID: O20050510000912 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Community Medical Center, Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1881643484 PECOS PAC ID: 6608776943 Enrollment ID: O20061222000136 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Memorial Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881603850 PECOS PAC ID: 1355394040 Enrollment ID: O20100213000119 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Howard County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154626216 PECOS PAC ID: 5698775849 Enrollment ID: O20110614000460 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Nebraska Pulmonary Specialties Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669728457 PECOS PAC ID: 3072412881 Enrollment ID: O20121026000145 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Beatrice Community Hospital & Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922111855 PECOS PAC ID: 1951208222 Enrollment ID: O20121214000477 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Think Aksarben Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316357676 PECOS PAC ID: 9638394505 Enrollment ID: O20140819000301 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Grand Island Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225658495 PECOS PAC ID: 0143659508 Enrollment ID: O20200904000271 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Chi Health Clinic Specialty Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285138065 PECOS PAC ID: 4789098443 Enrollment ID: O20210121000492 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Bryan Hospital Kearney |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033875380 PECOS PAC ID: 5991195547 Enrollment ID: O20211214002678 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Clay County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134163389 PECOS PAC ID: 6901959436 Enrollment ID: O20220926000419 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Phillips County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639264492 PECOS PAC ID: 7012231251 Enrollment ID: O20230209000918 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Entity Name | Shelby County Chris A Myrtue Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922184175 PECOS PAC ID: 5193619393 Enrollment ID: O20231101001600 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harvey Aj Hopkins, MD 1500 S. 48th Street, Suite 800, Lincoln, NE 68506-1200 Ph: (402) 483-8600 | Dr Harvey Aj Hopkins, MD 1500 S. 48th Street, Suite 800, Lincoln, NE 68506-1200 Ph: (402) 483-8600 |
News Archive
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.
Aging men with low testosterone levels who take testosterone replacement therapy are at a slightly greater risk of experiencing an ischemic stroke, transient ischemic attack, or myocardial infarction, especially during the first two years of use, reports a study appearing in The American Journal of Medicine, published by Elsevier.
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
The Food and Drug Administration (FDA) has replied to the claims from cigarette makers that new graphic-warning labels due to take effect next year violate tobacco companies' free speech rights.
› Verified 7 days ago
Ted M Triggs, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 | |
Joseph L Kummer, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 S 48th St, Suite 600, Lincoln, NE 68506 Phone: 402-483-3333 Fax: 402-483-3297 | |
Brenda Kay Bell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1919 S 40th, Ste 207, Lincoln, NE 68506 Phone: 402-489-3383 Fax: 402-489-3789 | |
Scott Allen Heasty, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-4780 Fax: 402-481-5377 | |
Scott Charles Rasmussen, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3901 Pine Lake Rd, Suite 220, Lincoln, NE 68516 Phone: 402-421-3240 Fax: 402-423-0739 | |
Jeffrey E Jarrett, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 S 48th St, Suite 800, Lincoln, NE 68506 Phone: 402-483-8600 Fax: 402-483-8689 | |
Tracy L Slocum Farritor, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 |